首页 > 最新文献

Case reports in pancreatic cancer最新文献

英文 中文
Completion Pancreaticoduodenectomy for a Second Primary Pancreatic Cancer: A Case Report. 完全性胰十二指肠切除术治疗第二原发性胰腺癌1例报告。
Pub Date : 2016-06-01 eCollection Date: 2016-01-01 DOI: 10.1089/crpc.2016.0010
Jeffrey M Hardacre

Background: Recurrent pancreatic cancer may represent a true local recurrence or a second intrapancreatic primary. Resection of recurrent pancreatic cancer is uncommon. Case Presentation: A 68-year-old woman underwent a distal pancreatectomy/splenectomy for pancreatic adenocarcinoma after presenting with acute pancreatitis. She received 6 months of adjuvant gemcitabine. Nearly 5 years later, she presented with acute pancreatitis. Endoscopic ultrasonography suggested malignant degeneration of an uncinate intraductal papillary mucinous neoplasm (IPMN), but the cytology was negative. She subsequently underwent a completion pancreaticoduodenectomy for what proved to be a second pancreatic adenocarcinoma. Conclusion: Although uncommon, repeat resection for a second pancreatic cancer may be appropriate in select patients. Careful attention to the remnant pancreas must be maintained on surveillance imaging.

背景:复发的胰腺癌可能代表真正的局部复发或胰腺内的第二次原发。复发性胰腺癌切除术并不常见。病例介绍:一名68岁女性在出现急性胰腺炎后,接受了胰腺癌远端胰腺切除术/脾切除术。她接受了6个月的吉西他滨辅助治疗。近5年后,她出现急性胰腺炎。超声内镜提示钩状导管内乳头状粘液瘤(IPMN)恶性变性,但细胞学检查为阴性。随后,她接受了完全胰十二指肠切除术,证实是第二胰腺腺癌。结论:虽然不常见,但在某些患者中,重复切除第二次胰腺癌是合适的。在监视影像上必须保持对残余胰腺的仔细注意。
{"title":"Completion Pancreaticoduodenectomy for a Second Primary Pancreatic Cancer: A Case Report.","authors":"Jeffrey M Hardacre","doi":"10.1089/crpc.2016.0010","DOIUrl":"https://doi.org/10.1089/crpc.2016.0010","url":null,"abstract":"<p><p><b>Background:</b> Recurrent pancreatic cancer may represent a true local recurrence or a second intrapancreatic primary. Resection of recurrent pancreatic cancer is uncommon. <b>Case Presentation:</b> A 68-year-old woman underwent a distal pancreatectomy/splenectomy for pancreatic adenocarcinoma after presenting with acute pancreatitis. She received 6 months of adjuvant gemcitabine. Nearly 5 years later, she presented with acute pancreatitis. Endoscopic ultrasonography suggested malignant degeneration of an uncinate intraductal papillary mucinous neoplasm (IPMN), but the cytology was negative. She subsequently underwent a completion pancreaticoduodenectomy for what proved to be a second pancreatic adenocarcinoma. <b>Conclusion:</b> Although uncommon, repeat resection for a second pancreatic cancer may be appropriate in select patients. Careful attention to the remnant pancreas must be maintained on surveillance imaging.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"50-52"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2016.0010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36855180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Colloid Carcinoma of the Pancreas: Case Report and Review of the Literature. 胰腺胶体癌:1例报告及文献复习。
Pub Date : 2016-06-01 eCollection Date: 2016-01-01 DOI: 10.1089/crpc.2016.0006
Sonia T Orcutt, Domenico Coppola, Pamela J Hodul

Background: Colloid carcinoma of the pancreas is a rare type of pancreatic cancer that has a more indolent course and superior long-term survival compared to ductal adenocarcinoma. There is a dearth of literature describing this diagnosis due to its rarity and its only recent recognition as a distinct clinical entity. We present two cases of patients with colloid carcinoma and discuss the presentation and management of this disease. Case Presentation: A 58-year-old man with repeated bouts of pancreatitis and a 72-year-old woman with symptoms of pancreatic exocrine and endocrine insufficiency were both found to have cystic masses in the head of the pancreas. Both were identified as having at least mixed main duct/side branch intraductal papillary mucinous neoplasms (IPMNs) on appropriate workup with additional imaging and endoscopy. Pancreaticoduodenectomy was recommended. Both patients, however, were noted to have high-grade dysplasia at the resection margin intraoperatively on frozen section, and thus, total pancreatectomies were performed. Final pathology in each case demonstrated colloid carcinoma with no nodal spread of disease. The patients recovered well. Adjuvant chemotherapy was recommended. Conclusion: Colloid carcinoma of the pancreas is a rare pathologic diagnosis and is frequently associated with IPMN. Colloid carcinomas tend to present at earlier stages than do ductal adenocarcinomas and are known to have improved long-term survival. Surgical and systemic options for treatment parallel that of ductal adenocarcinoma due to the rarity of the diagnosis and the lack of trials assessing therapy for this specific diagnosis.

背景:胰腺胶质癌是一种罕见的胰腺癌类型,与导管腺癌相比,它的病程更缓慢,长期生存率更高。由于其罕见性和最近才被认为是一种独特的临床实体,因此缺乏文献描述这种诊断。我们报告了两例胶质癌患者,并讨论了这种疾病的表现和治疗。病例介绍:一名58岁男性反复发作的胰腺炎和一名72岁女性胰腺外分泌和内分泌功能不全的症状都被发现在胰腺头部有囊性肿块。通过适当的影像学检查和内窥镜检查,两例患者均被确定为至少有主导管/侧分支导管内乳头状粘液瘤(IPMNs)。建议行胰十二指肠切除术。然而,两例患者术中冰冻切片发现切除边缘高度发育不良,因此,进行了全胰切除术。每个病例的最终病理均显示胶体癌,无淋巴结扩散。病人恢复得很好。建议辅助化疗。结论:胰腺胶质癌是一种罕见的病理诊断,常与IPMN相关。胶体癌往往比导管腺癌更早出现,并且已知其长期生存率更高。由于诊断的罕见性和缺乏针对这种特殊诊断的评估治疗的试验,手术和全身治疗的选择与导管腺癌相似。
{"title":"Colloid Carcinoma of the Pancreas: Case Report and Review of the Literature.","authors":"Sonia T Orcutt,&nbsp;Domenico Coppola,&nbsp;Pamela J Hodul","doi":"10.1089/crpc.2016.0006","DOIUrl":"https://doi.org/10.1089/crpc.2016.0006","url":null,"abstract":"<p><p><b>Background:</b> Colloid carcinoma of the pancreas is a rare type of pancreatic cancer that has a more indolent course and superior long-term survival compared to ductal adenocarcinoma. There is a dearth of literature describing this diagnosis due to its rarity and its only recent recognition as a distinct clinical entity. We present two cases of patients with colloid carcinoma and discuss the presentation and management of this disease. <b>Case Presentation:</b> A 58-year-old man with repeated bouts of pancreatitis and a 72-year-old woman with symptoms of pancreatic exocrine and endocrine insufficiency were both found to have cystic masses in the head of the pancreas. Both were identified as having at least mixed main duct/side branch intraductal papillary mucinous neoplasms (IPMNs) on appropriate workup with additional imaging and endoscopy. Pancreaticoduodenectomy was recommended. Both patients, however, were noted to have high-grade dysplasia at the resection margin intraoperatively on frozen section, and thus, total pancreatectomies were performed. Final pathology in each case demonstrated colloid carcinoma with no nodal spread of disease. The patients recovered well. Adjuvant chemotherapy was recommended. <b>Conclusion:</b> Colloid carcinoma of the pancreas is a rare pathologic diagnosis and is frequently associated with IPMN. Colloid carcinomas tend to present at earlier stages than do ductal adenocarcinomas and are known to have improved long-term survival. Surgical and systemic options for treatment parallel that of ductal adenocarcinoma due to the rarity of the diagnosis and the lack of trials assessing therapy for this specific diagnosis.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"40-45"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2016.0006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36855178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Pancreatic Cancer in Lynch Syndrome: A Case Report. 胰腺癌合并Lynch综合征1例报告。
Pub Date : 2016-05-01 eCollection Date: 2016-01-01 DOI: 10.1089/crpc.2016.0007
Madiha Gilani, Charles M Intenzo, Voichita Bar-Ad, Harish Lavu, Ashwin R Sama

Background: In the literature, pancreatic cancer is not frequently acknowledged among the tumors that are considered a part of Lynch Syndrome. Case Presentation: Our case is one of a young man who was found, very early in life, to have pancreatic cancer. His tumor demonstrated germline microsatellite instability, and hence by definition the patient has Lynch syndrome. He responded well to treatment, which included surgery and adjuvant chemotherapy. To date he remains in remission from pancreatic cancer. Conclusion: The rare instances in this case report include: (a) The patient had pancreatic cancer that fulfilled the histopathological and clinical criteria for Lynch syndrome. (b) Pancreatic cancer was diagnosed earlier in our patient than is expected in patients who suffer from pancreatic cancer as a part of Lynch syndrome. (c) Our patient had an excellent response to chemotherapy. He remains in remission to date from pancreatic cancer and is 5 years since his last treatment for this disease.

背景:在文献中,胰腺癌在被认为是Lynch综合征的一部分的肿瘤中并不常见。病例介绍:我们的病例是一个年轻人,他在生命的早期就被发现患有胰腺癌。他的肿瘤表现出生殖系微卫星不稳定,因此根据定义,患者患有林奇综合征。他对包括手术和辅助化疗在内的治疗反应良好。到目前为止,他的胰腺癌仍处于缓解期。结论:本病例报告的罕见病例包括:(a)患者患有胰腺癌,符合Lynch综合征的组织病理学和临床标准。(b)本例患者胰腺癌的诊断时间早于Lynch综合征患者胰腺癌的诊断时间。我们的病人对化疗有很好的反应。到目前为止,他的胰腺癌仍处于缓解期,距离他最后一次治疗胰腺癌已有5年了。
{"title":"Pancreatic Cancer in Lynch Syndrome: A Case Report.","authors":"Madiha Gilani,&nbsp;Charles M Intenzo,&nbsp;Voichita Bar-Ad,&nbsp;Harish Lavu,&nbsp;Ashwin R Sama","doi":"10.1089/crpc.2016.0007","DOIUrl":"https://doi.org/10.1089/crpc.2016.0007","url":null,"abstract":"<p><p><b>Background:</b> In the literature, pancreatic cancer is not frequently acknowledged among the tumors that are considered a part of Lynch Syndrome. <b>Case Presentation:</b> Our case is one of a young man who was found, very early in life, to have pancreatic cancer. His tumor demonstrated germline microsatellite instability, and hence by definition the patient has Lynch syndrome. He responded well to treatment, which included surgery and adjuvant chemotherapy. To date he remains in remission from pancreatic cancer. <b>Conclusion:</b> The rare instances in this case report include: (a) The patient had pancreatic cancer that fulfilled the histopathological and clinical criteria for Lynch syndrome. (b) Pancreatic cancer was diagnosed earlier in our patient than is expected in patients who suffer from pancreatic cancer as a part of Lynch syndrome. (c) Our patient had an excellent response to chemotherapy. He remains in remission to date from pancreatic cancer and is 5 years since his last treatment for this disease.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"36-39"},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2016.0007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36855177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer. 高剂量维生素D3在胰腺癌中的偶然使用。
Pub Date : 2016-05-01 eCollection Date: 2016-01-01 DOI: 10.1089/crpc.2016.0003
Timothy L Cannon, Joel Ford, Danubia Hester, Donald L Trump

Background: Pancreatic adenocarcinoma is associated with a very poor prognosis, with a 5 year survival of ∼7.2%. Vitamin D has long been evaluated for benefit as a protective agent and treatment for malignancies. Although cancer incidence and outcomes have been tied to vitamin D levels, there is no clear evidence that supplementation of vitamin D improves outcome in pancreatic cancer to date. Case Presentation: We present a patient who errantly took supratherapeutic doses of vitamin D 50,000 U daily, achieving a serum 25(OH)D level of more than 150 mg/mL, with no appreciable side effects. Conclusion: Her disease was stable for 8 months off of conventional treatment, although it is unclear whether this was related to vitamin D supplementation.

背景:胰腺腺癌的预后非常差,5年生存率约为7.2%。维生素D作为一种保护剂和治疗恶性肿瘤的益处早已被评估。虽然癌症的发病率和预后与维生素D水平有关,但迄今为止没有明确的证据表明补充维生素D可以改善胰腺癌的预后。病例介绍:我们报告了一名患者,他每天服用超治疗剂量的维生素D 50,000 U,达到血清25(OH)D水平超过150 mg/mL,没有明显的副作用。结论:在常规治疗结束后的8个月,患者病情稳定,但尚不清楚这是否与补充维生素D有关。
{"title":"The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer.","authors":"Timothy L Cannon,&nbsp;Joel Ford,&nbsp;Danubia Hester,&nbsp;Donald L Trump","doi":"10.1089/crpc.2016.0003","DOIUrl":"https://doi.org/10.1089/crpc.2016.0003","url":null,"abstract":"<p><p><b>Background:</b> Pancreatic adenocarcinoma is associated with a very poor prognosis, with a 5 year survival of ∼7.2%. Vitamin D has long been evaluated for benefit as a protective agent and treatment for malignancies. Although cancer incidence and outcomes have been tied to vitamin D levels, there is no clear evidence that supplementation of vitamin D improves outcome in pancreatic cancer to date. <b>Case Presentation:</b> We present a patient who errantly took supratherapeutic doses of vitamin D 50,000 U daily, achieving a serum 25(OH)D level of more than 150 mg/mL, with no appreciable side effects. <b>Conclusion:</b> Her disease was stable for 8 months off of conventional treatment, although it is unclear whether this was related to vitamin D supplementation.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"32-35"},"PeriodicalIF":0.0,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2016.0003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36855176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Taking the Lead: A Case Report of a Leiomyoma Causing Duodeno-Duodenal Intussusception and Review of Literature. 率先垂范:十二指肠-十二指肠肠套叠的子宫乳头状瘤病例报告及文献综述。
Pub Date : 2016-04-01 eCollection Date: 2016-01-01 DOI: 10.1089/crpc.2016.0001
Louis F Chai, Philip M Batista, Harish Lavu

Background: Duodenal masses are rare entities and symptomatic presentation generally is due to abdominal pain or the presence of gastrointestinal bleeding. A number of published case reports in the literature have detailed various neoplasms that have caused an intussusception isolated to the duodenum. This is a particularly unusual phenomenon due to the location and fixation of this portion of the proximal small bowel to the retroperitoneum. We present here a case of duodeno-duodenal intussusception secondary to a leiomyoma. Case: A 65-year-old Caucasian male presented with intermittent bloody stools and syncope over a 9-month period secondary to a duodenal leiomyoma causing intussusception, which was treated through a pancreaticoduodenectomy. Conclusion: Intussusception of the duodenum is an uncommon entity and the diagnosis of a leiomyoma should be considered in the setting of a potential mass in the small intestine.

背景:十二指肠肿块是一种罕见的实体肿瘤,症状通常表现为腹痛或消化道出血。文献中发表的一些病例报告详细描述了各种肿瘤引起的十二指肠肠套叠。由于这部分近端小肠的位置和与腹膜后的固定,这是一种特别不寻常的现象。我们在此介绍一例继发于十二指肠肌瘤的十二指肠-十二指肠肠套叠病例。病例:一名 65 岁的白种男性在 9 个月内出现间歇性血便和晕厥,继发于十二指肠左侧肌瘤引起的肠套叠,通过胰十二指肠切除术进行了治疗。结论十二指肠肠套叠并不常见,在小肠内发现潜在肿块时应考虑十二指肠利肌瘤的诊断。
{"title":"Taking the Lead: A Case Report of a Leiomyoma Causing Duodeno-Duodenal Intussusception and Review of Literature.","authors":"Louis F Chai, Philip M Batista, Harish Lavu","doi":"10.1089/crpc.2016.0001","DOIUrl":"10.1089/crpc.2016.0001","url":null,"abstract":"<p><p><b><i>Background:</i></b> Duodenal masses are rare entities and symptomatic presentation generally is due to abdominal pain or the presence of gastrointestinal bleeding. A number of published case reports in the literature have detailed various neoplasms that have caused an intussusception isolated to the duodenum. This is a particularly unusual phenomenon due to the location and fixation of this portion of the proximal small bowel to the retroperitoneum. We present here a case of duodeno-duodenal intussusception secondary to a leiomyoma. <b><i>Case:</i></b> A 65-year-old Caucasian male presented with intermittent bloody stools and syncope over a 9-month period secondary to a duodenal leiomyoma causing intussusception, which was treated through a pancreaticoduodenectomy. <b><i>Conclusion:</i></b> Intussusception of the duodenum is an uncommon entity and the diagnosis of a leiomyoma should be considered in the setting of a potential mass in the small intestine.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"19-22"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36896674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solid Pseudopapillary Tumor of the Pancreas in a 50-Year-Old Man: A Case Report and Review of the Literature. 50岁男性胰腺实性假乳头瘤1例报告及文献复习。
Pub Date : 2016-04-01 eCollection Date: 2016-01-01 DOI: 10.1089/crpc.2016.0002
Xie Hongjian, Li Dujuan, Xue Shuang, Zhao Yuewu, Kong Lingfei

Background: A solid pseudopapillary tumor (SPT) of the pancreas is a rare neoplasm with low malignancy, constituting about 2% of pancreatic tumors, which mainly occurs in young women. Case Presentation: We herein report a case of a small SPT arising from the head of the pancreas in an asymptomatic 50-year-old man. This patient was admitted to our department at Henan Provincial People's Hospital for the evaluation of a pancreatic mass and a pancreatic resection was performed. Histology revealed the lesion to be an SPT of the pancreas, with the characteristic pseudopapilla formation, central degeneration, and capsule formation. The tumor was positive for vimentin, CD10, α1-antichymotrypsin, α1-antitrypsin, β-catenin, neuron-specific enolase, synaptophysin, and progesterone receptor. Conclusion: We diagnosed an SPT in the patient based on these histological findings and immunophenotype.

背景:胰腺实性假乳头状瘤(SPT)是一种罕见的低恶性肿瘤,约占胰腺肿瘤的2%,多见于年轻女性。病例介绍:我们在此报告一例小的SPT从胰腺的头部出现在一个无症状的50岁男性。该患者在河南省人民医院我科接受胰腺肿块评估并行胰腺切除术。组织学显示病变为胰腺SPT,伴特征性假乳头形成、中枢性变性和囊状形成。肿瘤呈波形蛋白、CD10、α1-抗凝乳胰蛋白酶、α1-抗胰蛋白酶、β-连环蛋白、神经元特异性烯醇化酶、突触素、孕酮受体阳性。结论:我们根据这些组织学发现和免疫表型诊断患者为SPT。
{"title":"Solid Pseudopapillary Tumor of the Pancreas in a 50-Year-Old Man: A Case Report and Review of the Literature.","authors":"Xie Hongjian,&nbsp;Li Dujuan,&nbsp;Xue Shuang,&nbsp;Zhao Yuewu,&nbsp;Kong Lingfei","doi":"10.1089/crpc.2016.0002","DOIUrl":"https://doi.org/10.1089/crpc.2016.0002","url":null,"abstract":"<p><p><b><i>Background:</i></b> A solid pseudopapillary tumor (SPT) of the pancreas is a rare neoplasm with low malignancy, constituting about 2% of pancreatic tumors, which mainly occurs in young women. <b><i>Case Presentation:</i></b> We herein report a case of a small SPT arising from the head of the pancreas in an asymptomatic 50-year-old man. This patient was admitted to our department at Henan Provincial People's Hospital for the evaluation of a pancreatic mass and a pancreatic resection was performed. Histology revealed the lesion to be an SPT of the pancreas, with the characteristic pseudopapilla formation, central degeneration, and capsule formation. The tumor was positive for vimentin, CD10, α1-antichymotrypsin, α1-antitrypsin, β-catenin, neuron-specific enolase, synaptophysin, and progesterone receptor. <b><i>Conclusion:</i></b> We diagnosed an SPT in the patient based on these histological findings and immunophenotype.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"23-27"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2016.0002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36896675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
"The Immune Conundrum": Acquired Hemophilia A, Immune Thrombocytopenia, and Neutropenia in a Patient with Pancreatic Cancer. “免疫难题”:获得性血友病A、免疫性血小板减少症和中性粒细胞减少症在胰腺癌患者。
Pub Date : 2016-01-01 DOI: 10.1089/crpc.2015.29011.prg
Praveen Ramakrishnan Geethakumari, Ashwin Sama, Jaime G Caro, Charles J Yeo, Srikanth Nagalla

Background: Malignancy-associated bleeding can pose diagnostic dilemmas. We report a unique case of paraneoplastic acquired hemophilia A (AHA), immune thrombocytopenia (ITP), and immune neutropenia in a patient with pancreatic adenocarcinoma. Case Presentation: A 66-year-old male with newly diagnosed pancreatic cancer and normal preoperative hematological evaluation was taken to the operating room for pancreaticoduodenectomy. The operation was aborted due to empyema of the gall bladder, cholangitis, and local extent of disease. Postoperatively, the patient developed bleeding diatheses with mucocutaneous and intra-abdominal bleeding and a prolonged activated partial thromboplastin time. Evaluation revealed high-titer factor VIII inhibitor confirming AHA. Management with bypassing agents such as recombinant activated factor VII, factor VIII inhibitor bypassing activity, and immunosuppression with steroids, cyclophosphamide, and rituximab achieved remission in 2 months. ITP developed after achieving normal factor VIII levels, which was managed with intravenous immunoglobulin. Neutropenia was detected before initiation of chemotherapy and was managed with granulocyte-colony stimulating factor. Conclusion: These unique challenges posed by paraneoplastic hematological syndromes warrant the need for astute clinical judgment and multidisciplinary collaboration for effective management.

背景:恶性肿瘤相关出血可造成诊断困境。我们报告一个独特的病例副肿瘤性获得性血友病a (AHA),免疫性血小板减少症(ITP),和免疫中性粒细胞减少症的胰腺腺癌患者。病例介绍:66岁男性,新诊断为胰腺癌,术前血液学检查正常,被送往手术室行胰十二指肠切除术。手术因胆囊脓肿、胆管炎及局部病变而流产。术后,患者出现出血性糖尿病伴皮肤粘膜和腹腔内出血,激活部分凝血活酶时间延长。评估显示高滴度因子VIII抑制剂证实AHA。使用重组活化因子7、因子8抑制剂等旁路药物,以及类固醇、环磷酰胺和利妥昔单抗的免疫抑制治疗,在2个月内获得缓解。ITP在达到正常因子VIII水平后发生,静脉注射免疫球蛋白进行治疗。化疗开始前检测到中性粒细胞减少,并使用粒细胞集落刺激因子进行治疗。结论:这些独特的挑战所提出的副肿瘤血液学综合征需要敏锐的临床判断和多学科合作的有效管理。
{"title":"\"The Immune Conundrum\": Acquired Hemophilia A, Immune Thrombocytopenia, and Neutropenia in a Patient with Pancreatic Cancer.","authors":"Praveen Ramakrishnan Geethakumari,&nbsp;Ashwin Sama,&nbsp;Jaime G Caro,&nbsp;Charles J Yeo,&nbsp;Srikanth Nagalla","doi":"10.1089/crpc.2015.29011.prg","DOIUrl":"https://doi.org/10.1089/crpc.2015.29011.prg","url":null,"abstract":"<p><p><b>Background:</b> Malignancy-associated bleeding can pose diagnostic dilemmas. We report a unique case of paraneoplastic acquired hemophilia A (AHA), immune thrombocytopenia (ITP), and immune neutropenia in a patient with pancreatic adenocarcinoma. <b>Case Presentation:</b> A 66-year-old male with newly diagnosed pancreatic cancer and normal preoperative hematological evaluation was taken to the operating room for pancreaticoduodenectomy. The operation was aborted due to empyema of the gall bladder, cholangitis, and local extent of disease. Postoperatively, the patient developed bleeding diatheses with mucocutaneous and intra-abdominal bleeding and a prolonged activated partial thromboplastin time. Evaluation revealed high-titer factor VIII inhibitor confirming AHA. Management with bypassing agents such as recombinant activated factor VII, factor VIII inhibitor bypassing activity, and immunosuppression with steroids, cyclophosphamide, and rituximab achieved remission in 2 months. ITP developed after achieving normal factor VIII levels, which was managed with intravenous immunoglobulin. Neutropenia was detected before initiation of chemotherapy and was managed with granulocyte-colony stimulating factor. <b>Conclusion:</b> These unique challenges posed by paraneoplastic hematological syndromes warrant the need for astute clinical judgment and multidisciplinary collaboration for effective management.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"14-18"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2015.29011.prg","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36896673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A Rare Case of Acinar Cell Cystadenoma in a 14-Year-Old Adolescent: A Case Report. 罕见的14岁青少年腺泡细胞囊腺瘤1例报告。
Pub Date : 2016-01-01 DOI: 10.1089/crpc.2015.29009.nco
Natalie Cosgrove, Joan DiPalma, Douglas Katz, Thomas Kowalski

Background: Acinar cell cystadenoma is a rare pancreatic cyst that has been described in several case reports. This lesion may be incidental or asymptomatic, occurs predominately in females, and has a mean age of onset in the fourth decade. Case Presentation: A previously healthy 14-year-old male presented with abdominal pain. He was found to have a pancreatic cystic lesion on ultrasound and cross-sectional imaging. His diagnosis remained uncertain despite additional analysis, including endoscopic ultrasound with fine-needle aspiration. The patient underwent successful laparoscopic excision for definitive diagnosis and management with an unremarkable postoperative course. He was diagnosed with a multilocular acinar cell cystadenoma. Conclusion: Acinar cell cystadenoma is a rare pancreatic cyst whose true malignant potential is unknown. Although there are no formal recommendations for post-operative monitoring and the true risk of recurrence is unknown, we recommended every other year magnetic resonance imaging/magnetic resonance cholangiopancreatography for postresection surveillance for this patient due to the theoretical risk of recurrence with malignant transformation.

背景:腺泡细胞囊腺瘤是一种罕见的胰腺囊肿,已在几例病例报告中被描述。这种病变可能是偶然的,也可能是无症状的,主要发生在女性身上,平均发病年龄在40岁左右。病例介绍:先前健康的14岁男性,以腹痛表现。在超声和横断面成像中发现他有胰腺囊性病变。他的诊断仍然不确定,尽管进一步的分析,包括内镜超声细针穿刺。该患者接受了成功的腹腔镜切除,以明确诊断和处理,术后病程不明显。他被诊断为多室腺泡细胞囊腺瘤。结论:腺泡细胞囊腺瘤是一种罕见的胰腺囊肿,其真正的恶性潜能尚不清楚。虽然没有正式的术后监测建议,复发的真正风险尚不清楚,但由于理论上存在恶性转化复发的风险,我们建议每隔一年对该患者进行磁共振成像/磁共振胆管造影术后监测。
{"title":"A Rare Case of Acinar Cell Cystadenoma in a 14-Year-Old Adolescent: A Case Report.","authors":"Natalie Cosgrove,&nbsp;Joan DiPalma,&nbsp;Douglas Katz,&nbsp;Thomas Kowalski","doi":"10.1089/crpc.2015.29009.nco","DOIUrl":"https://doi.org/10.1089/crpc.2015.29009.nco","url":null,"abstract":"<p><p><b>Background:</b> Acinar cell cystadenoma is a rare pancreatic cyst that has been described in several case reports. This lesion may be incidental or asymptomatic, occurs predominately in females, and has a mean age of onset in the fourth decade. <b>Case Presentation:</b> A previously healthy 14-year-old male presented with abdominal pain. He was found to have a pancreatic cystic lesion on ultrasound and cross-sectional imaging. His diagnosis remained uncertain despite additional analysis, including endoscopic ultrasound with fine-needle aspiration. The patient underwent successful laparoscopic excision for definitive diagnosis and management with an unremarkable postoperative course. He was diagnosed with a multilocular acinar cell cystadenoma. <b>Conclusion:</b> Acinar cell cystadenoma is a rare pancreatic cyst whose true malignant potential is unknown. Although there are no formal recommendations for post-operative monitoring and the true risk of recurrence is unknown, we recommended every other year magnetic resonance imaging/magnetic resonance cholangiopancreatography for postresection surveillance for this patient due to the theoretical risk of recurrence with malignant transformation.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"3-5"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2015.29009.nco","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36896671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Medical Case Reporting for Pancreatic Cancer. 胰腺癌的医学病例报告
Pub Date : 2016-01-01 DOI: 10.1089/crpc.2015.29007.cjy
Charles J Yeo, Jordan L Schilling
2016 will be the start of our second volume of Case Reports in Pancreatic Cancer and we could not be more excited for the new year. Our launch in November 2015 was warmly received, and we collaborated with Pancreatic Cancer Action Network’s #WageHope campaign on Twitter. Additionally, we celebrated our official launch at the 10th Annual Pancreatic Cancer and Related Diseases Symposium along with Thomas Jefferson University, the Sidney Kimmel Cancer Center, and the Pancreatic Cancer Action Network. Even with a new year ahead of us, we still have many challenges ahead of us. Pancreatic cancer poses an enormous challenge to clinicians and cancer scientists. Despite efforts in the past 60 years, conventional treatments such as surgery and chemotherapy are not consistently successful. Pancreatic cancer rates have risen steadily for several years, and the disease results in more than 300,000 deaths globally each year. It is the fourth most common cause of cancer deaths in the United States and has a 5-year survival rate of less than 10% when considering all cases. Case reports offer an important opportunity to transfer medical knowledge and stimulate new ideas about clinical care and research direction. More medical reporting is needed to increase the medical knowledge of pancreatic cancer with the aim of leading to significant therapeutic and prognostic progress. It is out of this need for medical reporting that we launched Case Reports in Pancreatic Cancer as a premier online open access journal for clinicians and cancer scientists to report their medical experiences. We hope that Case Reports in Pancreatic Cancer will promote interest in pancreatic cancer and encourage medical reporting among researchers, physicians, surgeons, medical oncologists, radiation oncologists, gastroenterologists, and pathologists. Finally, we have recently added several new Associate Editors, some being international experts, to our expanding editorial board. We are looking forward to continued development of the Journal. Please reach out to us for more information. We look forward to your contribution.
{"title":"Medical Case Reporting for Pancreatic Cancer.","authors":"Charles J Yeo,&nbsp;Jordan L Schilling","doi":"10.1089/crpc.2015.29007.cjy","DOIUrl":"https://doi.org/10.1089/crpc.2015.29007.cjy","url":null,"abstract":"2016 will be the start of our second volume of Case Reports in Pancreatic Cancer and we could not be more excited for the new year. Our launch in November 2015 was warmly received, and we collaborated with Pancreatic Cancer Action Network’s #WageHope campaign on Twitter. Additionally, we celebrated our official launch at the 10th Annual Pancreatic Cancer and Related Diseases Symposium along with Thomas Jefferson University, the Sidney Kimmel Cancer Center, and the Pancreatic Cancer Action Network. Even with a new year ahead of us, we still have many challenges ahead of us. Pancreatic cancer poses an enormous challenge to clinicians and cancer scientists. Despite efforts in the past 60 years, conventional treatments such as surgery and chemotherapy are not consistently successful. Pancreatic cancer rates have risen steadily for several years, and the disease results in more than 300,000 deaths globally each year. It is the fourth most common cause of cancer deaths in the United States and has a 5-year survival rate of less than 10% when considering all cases. Case reports offer an important opportunity to transfer medical knowledge and stimulate new ideas about clinical care and research direction. More medical reporting is needed to increase the medical knowledge of pancreatic cancer with the aim of leading to significant therapeutic and prognostic progress. It is out of this need for medical reporting that we launched Case Reports in Pancreatic Cancer as a premier online open access journal for clinicians and cancer scientists to report their medical experiences. We hope that Case Reports in Pancreatic Cancer will promote interest in pancreatic cancer and encourage medical reporting among researchers, physicians, surgeons, medical oncologists, radiation oncologists, gastroenterologists, and pathologists. Finally, we have recently added several new Associate Editors, some being international experts, to our expanding editorial board. We are looking forward to continued development of the Journal. Please reach out to us for more information. We look forward to your contribution.","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2015.29007.cjy","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36896670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital Variants of Gastrointestinal Rotation Found at Resection of Hepatopancreatobiliary Tumors: A Case Series with Review of the Literature. 肝胰胆管肿瘤切除术中发现先天性胃肠道旋转变异:一个病例系列并文献复习。
Pub Date : 2016-01-01 DOI: 10.1089/crpc.2015.29010.dwr
David W Rittenhouse, Michael J Pucci, Jennifer L Brumbaugh, Charles J Yeo, Harish Lavu

Background: Gastrointestinal malrotation arises from intrauterine events that occur early in the first trimester of gestation, and can result in a midgut volvulus that classically presents in the neonatal period with bilious emesis. Gastrointestinal malrotation can present clinically with symptoms such as chronic abdominal pain or bowel obstruction, or remain completely asymptomatic only to be discovered as an incidental finding much later in life during surgical exploration for other diseases. We sought to identify the prevalence of gastrointestinal malrotation in patients undergoing surgical exploration for hepatopancreatobiliary (HPB) malignancy and describe the operative considerations of these cases. Case Presentation: We performed a retrospective review of our prospectively acquired HPB surgery database from January 1, 2006, to December 1, 2013. We identified three cases of gastrointestinal malrotation out of a total of 1220 HPB cases reviewed, which represents 0.2%. We found two cases of gastrointestinal malrotation in the setting of pancreatic ductal adenocarcinoma and one case in the setting of cholangiocarcinoma. All three patients underwent exploratory laparotomy with resection of their respective primary tumors. We searched the English literature for cases of HPB malignancy in the setting of gastrointestinal malrotation. Conclusion: Our case series and review of the literature underscore the rarity and complexity of these cases.

背景:胃肠道旋转不良是由妊娠早期发生的宫内事件引起的,可导致中肠扭转,这种扭转通常出现在新生儿期,伴有胆汁性呕吐。胃肠道旋转不良可在临床上表现为慢性腹痛或肠梗阻等症状,或保持完全无症状,但在以后的其他疾病的外科探索中偶然发现。我们试图确定在接受肝胰胆管(HPB)恶性肿瘤手术探查的患者中胃肠道旋转不良的患病率,并描述这些病例的手术注意事项。病例介绍:我们对2006年1月1日至2013年12月1日前瞻性获得的HPB手术数据库进行了回顾性审查。在1220例HPB病例中,我们发现了3例胃肠道旋转不良,占0.2%。我们发现2例在胰腺导管腺癌中出现胃肠道旋转异常,1例在胆管癌中出现。所有三名患者均接受了剖腹探查术,切除了各自的原发肿瘤。我们检索了英文文献中以胃肠旋转不良为背景的HPB恶性肿瘤病例。结论:我们的病例系列和文献综述强调了这些病例的罕见性和复杂性。
{"title":"Congenital Variants of Gastrointestinal Rotation Found at Resection of Hepatopancreatobiliary Tumors: A Case Series with Review of the Literature.","authors":"David W Rittenhouse,&nbsp;Michael J Pucci,&nbsp;Jennifer L Brumbaugh,&nbsp;Charles J Yeo,&nbsp;Harish Lavu","doi":"10.1089/crpc.2015.29010.dwr","DOIUrl":"10.1089/crpc.2015.29010.dwr","url":null,"abstract":"<p><p><b>Background:</b> Gastrointestinal malrotation arises from intrauterine events that occur early in the first trimester of gestation, and can result in a midgut volvulus that classically presents in the neonatal period with bilious emesis. Gastrointestinal malrotation can present clinically with symptoms such as chronic abdominal pain or bowel obstruction, or remain completely asymptomatic only to be discovered as an incidental finding much later in life during surgical exploration for other diseases. We sought to identify the prevalence of gastrointestinal malrotation in patients undergoing surgical exploration for hepatopancreatobiliary (HPB) malignancy and describe the operative considerations of these cases. <b>Case Presentation:</b> We performed a retrospective review of our prospectively acquired HPB surgery database from January 1, 2006, to December 1, 2013. We identified three cases of gastrointestinal malrotation out of a total of 1220 HPB cases reviewed, which represents 0.2%. We found two cases of gastrointestinal malrotation in the setting of pancreatic ductal adenocarcinoma and one case in the setting of cholangiocarcinoma. All three patients underwent exploratory laparotomy with resection of their respective primary tumors. We searched the English literature for cases of HPB malignancy in the setting of gastrointestinal malrotation. <b>Conclusion:</b> Our case series and review of the literature underscore the rarity and complexity of these cases.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"6-13"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2015.29010.dwr","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36896672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Case reports in pancreatic cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1